Cargando…
Runx1 Deficiency Protects Against Adverse Cardiac Remodeling After Myocardial Infarction
BACKGROUND: Myocardial infarction (MI) is a leading cause of heart failure and death worldwide. Preservation of contractile function and protection against adverse changes in ventricular architecture (cardiac remodeling) are key factors to limiting progression of this condition to heart failure. Con...
Autores principales: | McCarroll, Charlotte S., He, Weihong, Foote, Kirsty, Bradley, Ashley, Mcglynn, Karen, Vidler, Francesca, Nixon, Colin, Nather, Katrin, Fattah, Caroline, Riddell, Alexandra, Bowman, Peter, Elliott, Elspeth B., Bell, Margaret, Hawksby, Catherine, MacKenzie, Scott M., Morrison, Liam J., Terry, Anne, Blyth, Karen, Smith, Godfrey L., McBride, Martin W., Kubin, Thomas, Braun, Thomas, Nicklin, Stuart A., Cameron, Ewan R., Loughrey, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757664/ https://www.ncbi.nlm.nih.gov/pubmed/29030345 http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028911 |
Ejemplares similares
-
RUNX1: an emerging therapeutic target for cardiovascular disease
por: Riddell, Alexandra, et al.
Publicado: (2020) -
The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
por: Khan, Adiba S., et al.
Publicado: (2023) -
Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014) -
Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night
por: Sweeney, Kerri, et al.
Publicado: (2020) -
Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction
por: Fattah, Caroline, et al.
Publicado: (2016)